0 التعليقات
0 المشاركات
162 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Advanced Renal Cell Carcinoma Therapeutics Market: 7.3% CAGR Growth Through 2030According to a newly published market research report by 24LifeSciences, global advanced renal cell carcinoma therapeutics market was valued at USD 3.2 billion in 2023 and is projected to reach USD 5.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 20242030. Advanced renal cell carcinoma therapeutics encompass targeted therapies,...0 التعليقات 0 المشاركات 345 مشاهدة 0 معاينة
-
Advanced Renal Cell Carcinoma Therapeutics Market: 7.3% CAGR Growth Through 2030According to a newly published market research report by 24LifeSciences, global advanced renal cell carcinoma therapeutics market was valued at USD 3.2 billion in 2023 and is projected to reach USD 5.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 20242030. Advanced renal cell carcinoma therapeutics encompass targeted therapies,...0 التعليقات 0 المشاركات 329 مشاهدة 0 معاينة
-
Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"In-Depth Study on Executive Summary Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size and Share The Asia-Pacific natural killer (NK) cell therapeutics market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyzes that Asia-Pacific natural killer (NK) cell therapeutics market will grow at a CAGR of 45.2% during the forecast...0 التعليقات 0 المشاركات 543 مشاهدة 0 معاينة
-
Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"In-Depth Study on Executive Summary Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size and Share The Asia-Pacific natural killer (NK) cell therapeutics market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyzes that Asia-Pacific natural killer (NK) cell therapeutics market will grow at a CAGR of 45.2% during the forecast...0 التعليقات 0 المشاركات 592 مشاهدة 0 معاينة
-
Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis"Executive Summary Asia-Pacific Natural Killer (NK) Cell Therapeutics Market: Growth Trends and Share Breakdown The Asia-Pacific natural killer (NK) cell therapeutics market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyzes that Asia-Pacific natural killer (NK) cell therapeutics market will grow at a CAGR of 45.2% during the forecast...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Biotech Breakthroughs Accelerate the Global RNA Therapeutics MarketKey Drivers Impacting Executive Summary RNA Therapeutics Market Size and Share CAGR Value This global RNA Therapeutics Market research report carries out the methodical and comprehensive market research study that puts forth the facts and figures linked with any subject about RNA Therapeutics Market The forecast, analysis, evaluations, and estimations carried out in this RNA...0 التعليقات 0 المشاركات 217 مشاهدة 0 معاينة
-
Bispecific T Cell Engager Therapeutics Market to Grow at 15.8% CAGR (2025–2032)According to a newly published market research report by 24LifeSciences, global bispecific T cell engager therapeutics market was valued at USD 5.8 billion in 2024 and is projected to reach USD 20.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.8% during the forecast period 20252032. Bispecific T cell engagers (BiTEs) represent a revolutionary class of...0 التعليقات 0 المشاركات 341 مشاهدة 0 معاينة
-
Bispecific T Cell Engager Therapeutics Market to Grow at 15.8% CAGR (2025–2032)According to a newly published market research report by 24LifeSciences, global bispecific T cell engager therapeutics market was valued at USD 5.8 billion in 2024 and is projected to reach USD 20.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.8% during the forecast period 20252032. Bispecific T cell engagers (BiTEs) represent a revolutionary class of...0 التعليقات 0 المشاركات 324 مشاهدة 0 معاينة
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Breakthrough Neuroscience Research Expands AMPA Receptor Therapeutics MarketExecutive Summary α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Market Size and Share: Global Industry Snapshot The global α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor market size was valued at USD 274.69 million in 2024 and is expected to reach USD 431.25 million by 2032, at a CAGR of...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Antibody Drug Conjugates Market Expansion with New Cancer TherapiesNorth America currently holds a significant share in the antibody drug conjugates market due to strong research infrastructure and high healthcare spending. The presence of major pharmaceutical companies also supports regional growth. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023, registering...0 التعليقات 0 المشاركات 3كيلو بايت مشاهدة 0 معاينة
-
Are Calcimimetics Shaping the Future of Calcium Disorder Treatments?Calcimimetics Market Summary: According to the latest report published by Data Bridge Market Research, the Calcimimetics Market CAGR Value Calcimimetics Market is the finest market research report whicah is the result of proficient team and their potential capabilities. A strong research methodology consists of data models that include Market Overview and Guide, Vendor...0 التعليقات 0 المشاركات 871 مشاهدة 0 معاينة
-
Are Innovative Heart Failure Drugs Changing the Outlook for Cardiovascular Care?Executive Summary Heart Failure Drugs Market Size and Share Forecast CAGR Value Data Bridge Market Research analyses that the heart failure drugs market which was USD 8,010.62 million in 2023, would rocket up to USD 24,919.55 million by 2030, and is expected to undergo a CAGR of 15.56% during the forecast period. This Heart Failure Drugs Market Research Report also conducts analysis...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Are Prescription Drugs Driving the Next Era of Global Healthcare Innovation?Key Drivers Impacting Executive Summary Prescription Drugs Market Size and Share CAGR Value The global prescription drugs market size was valued at USD 1,230.28 billion in 2024 and is expected to reach USD 2,451.41 billion by 2032, at a CAGR of 9.00% during the forecast period The large-scale Prescription Drugs Market report presents the best...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Biologics and Biosimilars Market by 2031 – Segmentation Analysis, Trends, and Key PlayersThe biologics and biosimilars market is poised for significant growth over the next decade, driven by rising demand for advanced therapies to treat chronic, autoimmune, and life-threatening diseases. Biologics, complex medicines derived from living organisms, are increasingly preferred for their targeted therapeutic effects, while biosimilars offer highly similar alternatives at reduced costs,...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Biosimilars Market Opportunities for Pharma and Biotech CompaniesThe increasing role of biosimilars in hospital treatment protocols is another factor driving market growth. Hospitals are adopting biosimilars to manage healthcare budgets effectively. This shift is improving patient access to essential biologic therapies. The global Biosimilars Market is experiencing remarkable growth as healthcare systems increasingly adopt cost-effective alternatives...0 التعليقات 0 المشاركات 3كيلو بايت مشاهدة 0 معاينة
الصفحات المعززة
إعلان مُمول
إعلان مُمول
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek